Search research articles
Contact Us
Filters
Showing results (401-410 of 409) with videos related to
Page
of 41
Sort By:
You have reached the last page of results.
This site can display upto 409 results.
Chinese Medical Journal
|
December 5, 2018
Safety, Effectiveness, and Manipulability of Peritoneal Dialysis Machines Made in China: A Randomized, Crossover, Multicenter Clinical Study
Xue-Ying Cao, Ya-Ni He, Jian-Hui Zhou, et al.
Chinese Medical Journal
|
April 12, 2017
Analysis of Factors Associated with Death in Maintenance Hemodialysis Patients: A Multicenter Study in China
Kang-Kang Song, De-Long Zhao, Yuan-Da Wang, et al.
Plos One
|
March 6, 2014
Epidemiological and clinical characteristics and risk factors for death of patients with avian influenza A H7N9 virus infection from Jiangsu Province, Eastern China
Hong Ji, Qin Gu, Li-Ling Chen, et al.
Blood Purification
|
June 27, 2021
Relationships among the Dosage of Erythropoiesis-Stimulating Agents, Erythropoietin Resistance Index, and Mortality in Maintenance Hemodialysis Patients
Sai Pan, De-Long Zhao, Ping Li, et al.
Chinese Journal of Integrative Medicine
|
November 24, 2018
Effects of Niaoduqing Particles () on Delaying Progression of Renal Dysfunction: A Post-trial, Open-Label, Follow-up Study
Ying Zheng, Nian-Song Wang, Yu-Ning Liu, et al.
Chinese Medical Journal
|
October 21, 2017
Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
Ying Zheng, Guang-Yan Cai, Li-Qun He, et al.
Journal of Infection in Developing Countries
|
January 26, 2025
Evolutionary dynamics of SARS-CoV-2 variants under strict non-pharmaceutical interventions - a population-based study
Xiang Huo, Lunbiao Cui, Liguo Zhu, et al.
Journal of Integrative Medicine
|
February 16, 2021
Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial
Jie Wu, Shu-Wei Duan, Hong-Tao Yang, et al.
Chinese Medical Journal
|
June 22, 2013
Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients
Ying Zheng, Guang-Yan Cai, Xiang-Mei Chen, et al.
Page
of 41
Search research articles
Search
Showing results (401-410 of 409) with videos related to
Sort By:
Page
of 41
You have reached the last page of results.
This site can display upto 409 results.
Chinese Medical Journal
|
December 5, 2018
Safety, Effectiveness, and Manipulability of Peritoneal Dialysis Machines Made in China: A Randomized, Crossover, Multicenter Clinical Study
Xue-Ying Cao, Ya-Ni He, Jian-Hui Zhou, et al.
Chinese Medical Journal
|
April 12, 2017
Analysis of Factors Associated with Death in Maintenance Hemodialysis Patients: A Multicenter Study in China
Kang-Kang Song, De-Long Zhao, Yuan-Da Wang, et al.
Plos One
|
March 6, 2014
Epidemiological and clinical characteristics and risk factors for death of patients with avian influenza A H7N9 virus infection from Jiangsu Province, Eastern China
Hong Ji, Qin Gu, Li-Ling Chen, et al.
Blood Purification
|
June 27, 2021
Relationships among the Dosage of Erythropoiesis-Stimulating Agents, Erythropoietin Resistance Index, and Mortality in Maintenance Hemodialysis Patients
Sai Pan, De-Long Zhao, Ping Li, et al.
Chinese Journal of Integrative Medicine
|
November 24, 2018
Effects of Niaoduqing Particles () on Delaying Progression of Renal Dysfunction: A Post-trial, Open-Label, Follow-up Study
Ying Zheng, Nian-Song Wang, Yu-Ning Liu, et al.
Chinese Medical Journal
|
October 21, 2017
Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
Ying Zheng, Guang-Yan Cai, Li-Qun He, et al.
Journal of Infection in Developing Countries
|
January 26, 2025
Evolutionary dynamics of SARS-CoV-2 variants under strict non-pharmaceutical interventions - a population-based study
Xiang Huo, Lunbiao Cui, Liguo Zhu, et al.
Journal of Integrative Medicine
|
February 16, 2021
Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial
Jie Wu, Shu-Wei Duan, Hong-Tao Yang, et al.
Chinese Medical Journal
|
June 22, 2013
Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients
Ying Zheng, Guang-Yan Cai, Xiang-Mei Chen, et al.
Page
of 41